s. kahraman Et Al. , "HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy," Turkish Journal of Clinics and Laboratory , vol.16, no.2, pp.255-262, 2025
kahraman, s. Et Al. 2025. HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy. Turkish Journal of Clinics and Laboratory , vol.16, no.2 , 255-262.
kahraman, s., Hizal, M., Gumusay, O., Basaran, G., Seyyar, M., Sahin, E., ... Cabuk, D.(2025). HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy. Turkish Journal of Clinics and Laboratory , vol.16, no.2, 255-262.
kahraman, seda Et Al. "HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy," Turkish Journal of Clinics and Laboratory , vol.16, no.2, 255-262, 2025
kahraman, seda Et Al. "HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy." Turkish Journal of Clinics and Laboratory , vol.16, no.2, pp.255-262, 2025
kahraman, s. Et Al. (2025) . "HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy." Turkish Journal of Clinics and Laboratory , vol.16, no.2, pp.255-262.
@article{article, author={seda kahraman Et Al. }, title={HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy}, journal={Turkish Journal of Clinics and Laboratory}, year=2025, pages={255-262} }